Compared to the ailing business it was in the past, the Aurora Cannabis (NASDAQ: ACB) of today is making strategic moves, and it's also operating a lot more efficiently. With a bit more in the way of growth, it might just become a key player in the global medicinal cannabis scene.

But does that make the stock worth buying today, given the industry's ongoing shakeout? Let's examine the cases in favor and against purchasing it.

Aurora claims to have the largest market share of the medicinal cannabis market in Canada, and it also has decent positioning in other international medicinal markets like Poland.

Continue reading

Source Fool.com